The FDA approved an extended-release solution of bupivacaine and meloxicam (Zynrelef, Heron Therapeutics) to be used in adults for periarticular instillation to produce up to 72 hours of postoperative analgesia after bunionectomy, open inguinal herniorrhaphy and total knee arthroplasty, according to a company press release.
MAY 13, 2021